Advisory: Alert incorrectly tagged to Elevation Oncology withdrawn
25/09/2023 13:23
Sept 25 (Reuters) - An alert on residential energy solutions company
Elevation announcing a $20 million convertible note investment from Bernhard
Capital Partners wrongly tagged to unrelated biopharmaceutical firm Elevation
Oncology ELEV.O has been withdrawn.
There will be no substitute.
STORY_NUMBER: TUA4MJJCY
STORY_DATE: 25/09/2023
STORY_TIME: 12:13:13
((Bangalore.newsroom@thomsonreuters.com))
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing